Predicting progression to severe proliferative diabetic retinopathy
- PMID: 3579713
- DOI: 10.1001/archopht.1987.01060060096041
Predicting progression to severe proliferative diabetic retinopathy
Abstract
The longer-term progression of retinopathy was observed in a previously described group of 85 diabetic patients enrolled in the Early Treatment Diabetic Retinopathy Study. The probability of progression to severe retinopathy was significantly greater for eyes with the following baseline characteristics: greater overall retinopathy severity, higher fluorescein leakage, higher capillary nonperfusion, and lower electroretinographic oscillatory potential amplitudes. The summed amplitudes of the oscillatory potentials, the overall severity of retinopathy, and the severity of fluorescein angiographic leakage were found to be independent predictors of progression to severe proliferative retinopathy in a regression model; capillary nonperfusion was not found to predict progression independently when fluorescein leakage was included in the model. Probability curves based on the regression model can be used to support clinical decisions concerning when to perform panretinal laser photocoagulation and how often to follow up patients with less than severe proliferative diabetic retinopathy.
Similar articles
-
Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy.Arch Ophthalmol. 1987 Jul;105(7):929-33. doi: 10.1001/archopht.1987.01060070065030. Arch Ophthalmol. 1987. PMID: 3606452
-
Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.Doc Ophthalmol. 2018 Oct;137(2):121-129. doi: 10.1007/s10633-018-9655-9. Epub 2018 Sep 12. Doc Ophthalmol. 2018. PMID: 30209775
-
Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group.Ophthalmology. 1991 May;98(5 Suppl):834-40. Ophthalmology. 1991. PMID: 2062516 Clinical Trial.
-
The electroretinogram in diabetic retinopathy.Surv Ophthalmol. 1999 Jul-Aug;44(1):53-60. doi: 10.1016/s0039-6257(99)00063-6. Surv Ophthalmol. 1999. PMID: 10466588 Review.
-
Proliferative diabetic retinopathy.Insight. 2001 Jul-Sep;26(3):88-91; quiz 92-3. doi: 10.1067/min.2001.118675. Insight. 2001. PMID: 11677510 Review. No abstract available.
Cited by
-
Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes.Invest Ophthalmol Vis Sci. 2012 May 17;53(6):3040-6. doi: 10.1167/iovs.11-8226. Invest Ophthalmol Vis Sci. 2012. PMID: 22491405 Free PMC article.
-
Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities.Graefes Arch Clin Exp Ophthalmol. 1989;227(6):549-61. doi: 10.1007/BF02169451. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2483144
-
Retinal flow density by optical coherence tomography angiography is useful for detection of nonperfused areas in diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2275-2282. doi: 10.1007/s00417-018-4122-6. Epub 2018 Sep 6. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 30191299
-
Visual dysfunction associated with diabetic retinopathy.Curr Diab Rep. 2010 Oct;10(5):380-4. doi: 10.1007/s11892-010-0132-4. Curr Diab Rep. 2010. PMID: 20632133 Review.
-
Electrophysiological examination in uveitis: a review of the literature.Clin Ophthalmol. 2014;8:199-214. doi: 10.2147/OPTH.S54838. Epub 2014 Jan 10. Clin Ophthalmol. 2014. PMID: 24453476 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical